Market Data 
Markets
Replies to post #254908 on Biotech Values
03/28/25 10:23 PM
No doubt this is bad; however, I predict that a year from now biotech stocks will be higher and Marks won't be missed by biotech investors.
— Roy Friedman (@DewDiligence) March 29, 2025
The fallout may be painful, but I'm confident that it will be short-lived. In no way is the FDA "doomed." I think you'll come to regret having said that, Adam.
— Roy Friedman (@DewDiligence) March 29, 2025
04/01/25 5:35 PM
Scott Steele, Ph.D. has been named FDA’s Acting Director for the Center for Biologics Evaluation and Research (CBER).
— U.S. FDA (@US_FDA) April 1, 2025
Dr. Steele is a science, technology, and policy professional at FDA with extensive experience in multiple disciplines, including emerging science and technology,…
AI
